成都什么医院看睾丸精索静脉曲张成都{静脉扩张}造影费用,成都如何治疗老烂腿,成都肝血管瘤哪个医院看,成都治血管瘤哪家好,成都鲜红斑痣哪个医院治得好,成都治静脉曲张医院,成都哪个医院有治疗精索静脉曲张

XICHANG, Sichuan, Aug. 12 (Xinhua) -- China launched a communications satellite PAKSAT-1R for Pakistan at 0:15 a.m. Friday from the Xichang Satellite Launch Center in southwest China's Sichuan Province.The satellite was carried by a Long March-3B carrier rocket, according to the launch center. It is China's first in-orbit delivery to Asian customers and also the first commercial satellite export to international users this year.According to statistics from the control center, the satellite successfully separated from its carrier rocket and entered geostationary transfer orbit as scheduled, 26 minutes after being launched.PAKSAT-1R will provide a range of services, including broadband Internet, telecom and broadcasting, covering some regions of Europe, South Asia, the Middle East, and the eastern Africa.The contract for the PAKSAT-1R was signed in 2008 between China Great Wall Industry Corporation and the Space and Upper Atmosphere Research Commission of Pakistan.China and Pakistan share a long history of space technology cooperation. Pakistan's first low-orbit satellite, BADR-A, was launched by China in 1990 with Long March 2E rocket.

SAN FRANCISCO, July 28 (Xinhua) -- Global marketing and advertising research company Nielson on Thursday said in its latest survey that Google's Android operating system (OS) continued to dominate the U.S. smartphone market in June.According to Nielson's June survey of mobile consumers, the Android OS claims the largest share of the U.S. consumer smartphone market with 39 percent. Apple's iOS is in second place with 28 percent while RIM Blackberry is down to 20 percent.Microsoft's Windows Phone 7 OS had a 9 percent share of the market while HP webOS (Palm) accounted for 2 percent as did Nokia' s Symbian.In Nielson's May survey, 38 percent of smartphone consumers had a device powered by Android, compared to 27 percent for Apple's iOS for iPhones and 21 percent for RIM Blackberry.Talking about the manufacturer share, Apple is the No.1 in the U.S. as it is the only company manufacturing smartphones with the iOS, said the report.Other leading manufacturers include HTC, whose Android phones represents 14 percent of the smartphone market and whose Windows Mobile/WP7 devices accounted for 6 percent of the market.Motorola's Android devices are owned by 11 percent of smartphone consumers. Samsung's Android devices are used by 8 percent of smartphone consumers and its Windows Phone 7 devices take a 2 percent share, said Nielson.

BEIJING, Aug. 2 (Xinhuanet) -- The first close-up pictures of the asteroid Vesta, a protoplanet that dates back to the early days of the solar system, were revealed Monday by NASA scientists.The images were taken by the U.S. space agency's Dawn robotic probe, which is two weeks into a planned year-long survey of the second largest object in the main asteroid belt, located between Mars and Jupiter.About twice the size of California, Vesta is second in size only to Ceres, Dawn's next target and, along with Pluto, one of just five known dwarf planets. NASA is spending 466 million dollars to explore Vesta and Ceres during the course of a 10-year mission.Images from Dawn show Vesta a surprisingly diverse terrain and several unexplained geologic features. Chaotic terrain near the south pole is dominated by a towering central peak and huge ripple-like grooves stretching around its equatorial belt. Bright spots, dark pits and craters are filled with unexplained streaks of black and white debris. Terrain north of the grooves is much more heavily cratered.Scientists believe Vesta grew from a clump of gas and dust left over after the sun's birth some 4.65 billion years ago, a supernova explosion, which added radioactive materials to the growing body.Dawn will spend about a year circling Vesta, tweaking its orbit and altitude using an innovative technology called ion propulsion system, chief engineer Marc Rayman with NASA's Jet Propulsion Laboratory in California said.The ion propulsion system will enable Dawn to leave Vesta's orbit after a year of study and head off to Ceres, which is the largest object in the asteroid belt.

BEIJING, Aug. 24 (Xinhua) -- China will prioritize the development of six types of new materials in its new material industry over the next five years, the China Securities Journal said on Wednesday.The report cited an insider, who noted that the country's 12th Five-Year Plan (2011-2015) for the new material industry will come out in September, in which the government will launch key projects to support the development of the six materials.The six materials will be high-strength light alloy, advanced iron and steel, carbon fiber composite, new power battery material, function coated material, and rare earth function material, according to the report.The plan states each of the six sub industries will form a sizable industrial scale, with the industry's total output value to hit trillions of yuan by the end of 2015, and the self-supply rate to reach 70 percent during the period, the report said.Meanwhile, the government will also foster the development of materials in sectors such as green building material and the biomedical industry over the next five years, it added.

SYDNEY, July 15 (Xinhua) -- The world's first drug to increase life expectancy of people with advanced melanoma has been approved for use in Australia, local media reported on Friday.The breakthrough drug Yervoy got approval from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the most lethal form of skin cancer but for whom other treatments have failed, the Australian Associated Press (AAP) said.Clearance for the drug's use in Australia follows similar approvals by the U.S. health regulator in March.Yervoy works by attacking and destroying cancer cells.Patients are hooked up to an intravenous drip once every three weeks for a total of four doses.Professor Peter Hersey, consultant immunologist to the Melanoma Institute Australia, said no other drug had improved survival rates like Yervoy."Not all patients respond to it but those who do have a good chance of living longer than they would have otherwise," Hersey told AAP.While it may improve survival rates, Yervoy can produce side effects from diarrhea and vomiting to serious blood infections and kidney failure.The average survival time for people with advanced melanoma is just six months.A global study of 676 people with melanoma found that 45 percent of patients given Yervoy were still alive after one year, according to AAP.More than 20 percent lived at least two years, with a small number managing to survive for six years.A separate study, published in June, which showed similarly improved survival rates for patients with newly diagnosed advanced melanoma, has raised hopes that Yervoy could be made more widely available.Melanoma is the fourth most common cancer in Australia, with 10, 300 people diagnosed each year.